High prevalence of associated birth defects in congenital hypothyroidism

P Amaresh Reddy1, G Rajagopal, C V Harinarayan

  • 1Department of Endocrinology and Metabolism, Sri Venkateswara Institute of Medical Sciences, Tirupati 517507, India.

Insights

Congenital hypothyroidism in children is often linked to other birth defects. This study found that nearly 60% of patients had malformations, highlighting the need for cardiac screening.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Medical Genetics

Background:

  • Congenital hypothyroidism (CH) is a common endocrine disorder in newborns.
  • Associated congenital anomalies can impact patient management and outcomes.

Purpose of the Study:

  • To investigate the prevalence of dysmorphic features and anomalies in cardiac, skeletal, and urogenital systems among children with CH.
  • To determine the necessity of routine cardiac screening in CH patients.

Main Methods:

  • Seventeen children diagnosed with congenital primary hypothyroidism were evaluated.
  • Thyroid ultrasound and (99m)Tc radionuclide thyroid scintigraphy were used to determine the cause of CH.
  • Clinical examination, echocardiography, lumbar spine X-ray, and abdominal ultrasonography identified malformations.

Main Results:

  • Congenital malformations were present in 10 (59%) of the 17 patients.
  • Cardiac malformations, including atrial septal defect (ASD) and patent ductus arteriosus (PDA), occurred in 5 (29%) patients.
  • Neural tube defects, specifically spina bifida occulta, were found in 7 (41%) patients.

Conclusions:

  • Congenital hypothyroidism is frequently associated with congenital malformations.
  • Routine echocardiography is recommended for all patients diagnosed with congenital hypothyroidism to screen for cardiac defects.

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...